- Trials with a EudraCT protocol (142)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
142 result(s) found for: Cardiac Morbidity AND Morbidity.
Displaying page 1 of 8.
| EudraCT Number: 2017-001479-22 | Sponsor Protocol Number: NCT03021525 | Start Date*: 2017-08-04 |
| Sponsor Name:University Medical Center Hamburg-Eppendorf, Germany | ||
| Full Title: Individualized perioperative hemodynamic goal-directed therapy in major abdominal surgery (iPEGASUS-trial) | ||
| Medical condition: - Hemodynamic Instability - Cardiac Output - High Peroperative Complication | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-009467-59 | Sponsor Protocol Number: IJB-HIPEC-2009-01 | Start Date*: 2010-03-18 |
| Sponsor Name:Institut Jules Bordet | ||
| Full Title: Feasibility study of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy. | ||
| Medical condition: Inclusion criteria : 1. Histologically confirmed ovarian carcinoma or primary peritoneal carcinoma or Fallopian tube carcinoma. 2. FIGO stage III disease or only pleural stage IV disease 3. Age les... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-002090-12 | Sponsor Protocol Number: Ilocard | Start Date*: 2009-03-04 | |||||||||||
| Sponsor Name:Hospital of the university of munich | |||||||||||||
| Full Title: Effect of Iloprost inhalation before and during extracorporeal circulation (ECC) on perioperative morbidity and outcome in high risk cardiac surgical patients | |||||||||||||
| Medical condition: In this study effects of the intra operative, prophylactic inhalation of Iloprost (Ventavis) before and during extracorporal circulation on perioperative morbidity and outcome in high risk cardiac ... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-003181-12 | Sponsor Protocol Number: HOTPOT1 | Start Date*: 2016-10-07 |
| Sponsor Name:Royal College of Surgeons in Ireland | ||
| Full Title: Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? | ||
| Medical condition: Persistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition occurring in 7/1000 births and can result in significant cardiovascular instability in the newborn. It occur... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: IE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-009596-35 | Sponsor Protocol Number: | Start Date*: 2009-03-17 |
| Sponsor Name:Queen Mary's, University of London | ||
| Full Title: Optimisation of Peri-operative Cardiovascular Management to Improve Surgical Outcome (Optimise Trial) | ||
| Medical condition: Post-operative complications in patients who undergo major surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-006609-25 | Sponsor Protocol Number: MOOD-HF | Start Date*: 2008-05-27 | |||||||||||
| Sponsor Name:Julius Maximilians Universität Würzburg | |||||||||||||
| Full Title: Effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in Depressed Heart Failure patients | |||||||||||||
| Medical condition: To investigate the effects of selective serotonin re-uptake inhibition with the SSRI escitalopram on morbidity and mortality in depressed patients with CHF. The primary endpoint is the time to a fi... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-004141-90 | Sponsor Protocol Number: 4.0 | Start Date*: 2017-02-28 | ||||||||||||||||
| Sponsor Name:Queen Mary University of London | ||||||||||||||||||
| Full Title: Stopping Perioperative Angiotensin II Converting Enzyme inhibitors and/or receptor blockers in major non-cardiac surgery (SPACE): a phase II, explanatory, randomised controlled trial. | ||||||||||||||||||
| Medical condition: Myocardial injury (as measured by plasma troponin) after major surgery. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2011-001099-21 | Sponsor Protocol Number: 2010-04-23 | Start Date*: 2011-05-19 |
| Sponsor Name:Population Health Research Institute | ||
| Full Title: SIRS Steroids In caRdiac Surgery Trial | ||
| Medical condition: From available evidence, corticosteroids attenuate the inflammatory response to CPB which is felt to contribute to morbidity and mortality in cardiac surgery patients. The meta-analysis of the lite... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-013226-17 | Sponsor Protocol Number: AustrNHMRVID436677 | Start Date*: 2009-09-29 |
| Sponsor Name:Plymouth Hospitals NHS Trust | ||
| Full Title: The ENIGMA-II Trial. Nitrous oxide anaesthesia and cardiac morbidity after major surgery: a randomised controlled trial | ||
| Medical condition: The study investigates standard anaesthesia for surgery. There is no single specific 'disease' rather there is a population of patients requiring anaesthesia to permit surgery. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000442-21 | Sponsor Protocol Number: RC17_0029 | Start Date*: 2017-09-12 | |||||||||||
| Sponsor Name:CHU de Nantes | |||||||||||||
| Full Title: Effects of perioperative administration of dexamethasone on postoperative complications and mortality after non-cardiac major surgery : a randomized, multicentre, double blind, study | |||||||||||||
| Medical condition: non-cardiac major surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-003895-65 | Sponsor Protocol Number: DAL-301 | Start Date*: 2016-06-22 | |||||||||||
| Sponsor Name:DalCor Pharma UK Ltd, Leatherhead, Swiss Branch Zug | |||||||||||||
| Full Title: A phase III, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in a genetically defined population with a recent Acute Coronary Sy... | |||||||||||||
| Medical condition: This study is investigating the cardiovascular morbidity and mortality (cardiovascular death, resuscitated cardiac arrest, non-fatal myocardial infarction (MI) and non-fatal stroke) in subjects wit... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) BE (Completed) SE (Completed) SK (Completed) DK (Completed) FI (Completed) PT (Completed) DE (Completed) HU (Completed) ES (Ongoing) AT (Completed) CZ (Completed) BG (Completed) RO (Ongoing) PL (Completed) GB (GB - no longer in EU/EEA) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-001495-18 | Sponsor Protocol Number: 2010-04-23 | Start Date*: 2011-08-23 |
| Sponsor Name:Population health Research Institute | ||
| Full Title: Steroids in Cardiac Surgery (SIRS) trial | ||
| Medical condition: cardiac surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-015013-46 | Sponsor Protocol Number: AnaesthesiaResearch024 | Start Date*: 2009-12-14 |
| Sponsor Name:Alfred Health | ||
| Full Title: The ATACAS Trial: Aspirin and Tranexamic Acid for Coronary Artery Surgery Trial | ||
| Medical condition: Coronary Artery Bypass Grafting | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) IT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-003495-53 | Sponsor Protocol Number: NL59009.018.16 | Start Date*: 2016-11-29 |
| Sponsor Name:Academic Medical Center - Cardiology | ||
| Full Title: Prostacyclin receptor agonist Selexipag in patients with pulmonary arterial hypertension and congenital heart disease | ||
| Medical condition: Pulmonary arterial hypertension related to congenital heart disease. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-000919-22 | Sponsor Protocol Number: OMB114578 | Start Date*: 2011-09-14 | |||||||||||
| Sponsor Name:University of Liverpool [...] | |||||||||||||
| Full Title: RIAltO: A Randomised Investigation of Alternative Ofatumumab-containing regimens in less fit patients with CLL | |||||||||||||
| Medical condition: Chronic Lymphocytic Leukaemia | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-004213-41 | Sponsor Protocol Number: RIPAC | Start Date*: 2019-06-12 | |||||||||||
| Sponsor Name:University Hospital Ghent | |||||||||||||
| Full Title: Effect of intravenous replenishment of iron in the preoperative management of anemia in patients with colon cancer: RIPAC-trial | |||||||||||||
| Medical condition: M0-stage colon carcinoma with iron deficiency anemia defined by a Hb lower than 13 g/dl in men and 12g/dl in women with a transferrin saturation lower than 20% | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-003572-79 | Sponsor Protocol Number: SiewertIII | Start Date*: 2018-06-06 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | |||||||||||||
| Full Title: MULTICENTRY STAGE PHASE II NOT RANDOMIZED BY NEOADJUVANT THERAPY ACCORDING TO DOX DIAGNOSIS IN ADENOCARCINOMA SIEWERT III | |||||||||||||
| Medical condition: Adenocarcinoma of cardias siewert III | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-005337-31 | Sponsor Protocol Number: CHUB-fluides | Start Date*: 2015-02-23 | |||||||||||
| Sponsor Name:CHU Brugmann | |||||||||||||
| Full Title: Crystalloids or colloids for goal-directed fluid therapy with closed-loop assistance in major surgery? | |||||||||||||
| Medical condition: Major abdominal surgery, by laporotomy. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-006237-27 | Sponsor Protocol Number: CT/P004/HF/08/02_01 | Start Date*: 2009-10-12 | |||||||||||
| Sponsor Name:Torrent Pharmaceuticals Ltd. | |||||||||||||
| Full Title: Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as ... | |||||||||||||
| Medical condition: heart failure associated with impaired glucose tolerance or type 2 diabetes | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) GB (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2012-002834-36 | Sponsor Protocol Number: Retro-001 | Start Date*: 2012-09-13 |
| Sponsor Name:UMCG | ||
| Full Title: Evaluation of the effects of the addition of atropine during propofol/remifentanil induction of anesthesia on hemodynamics, microvascular blood flow and tissue oxygenenation in patients undergoing ... | ||
| Medical condition: ophthalmic surgery | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.